GISSILong-term effects of intravenous thrombolysis in acute myocardial infarction: Final report of the GISSI study. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet1987;2:871–4.
2.
ISIS-2. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet1998;2:349–59.
3.
LauJAntmanEMJimenez-SilvaJKupelnickBMostellerFChalmersTC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med1992;327:248–54.
4.
GUSTO Investigators.An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med1993;329:673–82.
5.
MidgetteASWongJBBeshanskyJRPorathAFlemingCPaukerSG. Cost-effectiveness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction. Med Decis Making1994;14:108–17.
6.
MarkDBHlatkyMACaliffRMLeeKLArmstrongPWBarbashGCost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med1995;332:1418–24.
7.
OddoneEZCowperPHamiltonGDMatcharDBHartiganPSamsaGCost effectiveness analysis of early zidovudine treatment of HIV infected patients. BMJ1993;307:1322–5.
